PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s disease (AD) and other neurodegenerative diseases, has announced a new epigenetics collaboration with Sheffield Hallam University, UK. This partnership will focus on ‘gen...
|